
T3 Defense surges 201% on tech expansion; NextCure jumps on short squeeze; biotech firms rise amid investigations.
T3 Defense's stock soared 201% following its subsidiary's expansion of defense technology into industrial materials, signaling strong growth potential. NextCure saw a 20.75% rise driven by a significant short squeeze, reflecting heavy short interest ...

